Cubist Systematic Strategies’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-16,362
| Closed | -$6.03K | – | 4674 |
|
|
2022
Q4 | $6.03K | Buy |
+16,362
| New | +$6.9K | ﹤0.01% | 4076 |
|
|
2022
Q3 | – | Sell |
-18,343
| Closed | -$14K | – | 4919 |
|
|
2022
Q2 | $14K | Buy |
+18,343
| New | +$16.2K | ﹤0.01% | 4248 |
|
|
2022
Q1 | – | Sell |
-65,504
| Closed | -$83K | – | 3900 |
|
|
2021
Q4 | $83K | Buy |
+65,504
| New | +$117K | ﹤0.01% | 3238 |
|
|
2021
Q3 | – | Sell |
-110,539
| Closed | -$415K | – | 3255 |
|
|
2021
Q2 | $415K | Buy |
110,539
+100,578
| +1,010% | +$350K | ﹤0.01% | 2128 |
|
|
2021
Q1 | $32K | Sell |
9,961
-24,131
| -71% | -$86.5K | ﹤0.01% | 2755 |
|
|
2020
Q4 | $116K | Buy |
34,092
+4,676
| +16% | +$19.2K | ﹤0.01% | 2383 |
|
|
2020
Q3 | $120K | Buy |
29,416
+11,395
| +63% | +$43.3K | ﹤0.01% | 2252 |
|
|
2020
Q2 | $61K | Buy |
18,021
+82
| +0.5% | +$239 | ﹤0.01% | 2256 |
|
|
2020
Q1 | $42K | Sell |
17,939
-27,315
| -60% | -$74.8K | ﹤0.01% | 2024 |
|
|
2019
Q4 | $165K | Buy |
45,254
+14,079
| +45% | +$114K | ﹤0.01% | 2085 |
|
|
2019
Q3 | $259K | Sell |
31,175
-65,019
| -68% | -$526K | 0.01% | 1632 |
|
|
2019
Q2 | $828K | Sell |
96,194
-2,988
| -3% | -$26.7K | 0.02% | 1147 |
|
|
2019
Q1 | $1.06M | Buy |
99,182
+15,271
| +18% | +$164K | 0.03% | 730 |
|
|
2018
Q4 | $734K | Buy |
83,911
+83,276
| +13,114% | +$1.06M | 0.03% | 722 |
|
|
2018
Q3 | $11K | Buy |
+635
| New | +$13.7K | ﹤0.01% | 1817 |
|
|
2018
Q1 | – | Sell |
-32,490
| Closed | -$616K | – | 2134 |
|
|
2017
Q4 | $616K | Buy |
+32,490
| New | +$589K | 0.03% | 753 |
|
|
2017
Q3 | – | Sell |
-10,720
| Closed | -$80K | – | 2050 |
|
|
2017
Q2 | $80K | Sell |
10,720
-8,261
| -44% | -$54K | 0.01% | 1485 |
|
|
2017
Q1 | $123K | Buy |
+18,981
| New | +$106K | 0.01% | 1342 |
|
|
2016
Q4 | – | Sell |
-21,732
| Closed | -$101K | – | 1936 |
|
|
2016
Q3 | $101K | Sell |
21,732
-4,793
| -18% | -$28.4K | 0.01% | 1471 |
|
|
2016
Q2 | $174K | Buy |
+26,525
| New | +$187K | 0.01% | 1380 |
|
|
2015
Q4 | – | Sell |
-18,900
| Closed | -$113K | – | 2004 |
|
|
2015
Q3 | $113K | Buy |
+18,900
| New | +$131K | 0.01% | 1607 |
|
|
2015
Q1 | – | Sell |
-14,462
| Closed | -$100K | – | 2124 |
|
|
2014
Q4 | $100K | Sell |
14,462
-1,368
| -9% | -$10.1K | 0.01% | 1696 |
|
|
2014
Q3 | $129K | Buy |
+15,830
| New | +$124K | 0.01% | 1496 |
|
Other funds holding SPPI
AC
SIG
ACM
Cubist Systematic Strategies's SPPI Position: Q1 2023 in Review
Cubist Systematic Strategies sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2023, closing a stake of 16,362 shares — an estimated $6.03K sold.
Cubist Systematic Strategies first reported a position in SPPI in Q3 2014 and held it in 23 quarters. The position peaked at $1.06M in Q1 2019. 69 funds tracked by Wall St. Rank hold SPPI as of Q1 2023.
- Cubist Systematic Strategies reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2023 after selling out during the quarter.
- Cubist Systematic Strategies sold 16,362 Spectrum Pharmaceuticals Inc shares in Q1 2023, an estimated $6.03K.
- Cubist Systematic Strategies first reported a position in Spectrum Pharmaceuticals Inc in Q3 2014 and held it in 23 quarters.
- Cubist Systematic Strategies's Spectrum Pharmaceuticals Inc position peaked at $1.06M in Q1 2019.
- 69 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2023.
Based on Cubist Systematic Strategies's 13F filing for Q1 2023, filed 15 May 2023.